HCMT
IMMU

Highland Capital Management (Texas)’s Immunomedics Inc IMMU Stock Holding History

Highland Capital Management (Texas)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-138,400
Closed -$562K – 335
2015
Q2 		$562K Hold
138,400
– – 0.01% 221
2015
Q1 		$530K Buy
+138,400
New +$602K 0.01% 211

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Highland Capital Management (Texas)'s IMMU Position: Q2 2019 in Review

Highland Capital Management (Texas) sold out of Immunomedics Inc (IMMU) in Q2 2019, closing a stake of 25,000 shares — an estimated $480K sold.

Highland Capital Management (Texas) first reported a position in IMMU in Q1 2015 and held it in 4 quarters. The position peaked at $1.13M in Q4 2017. 204 funds tracked by Wall St. Rank hold IMMU as of Q2 2019.

  • Highland Capital Management (Texas) reported no remaining Immunomedics Inc position as of Q2 2019 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 25,000 Immunomedics Inc shares in Q2 2019, an estimated $480K.
  • Highland Capital Management (Texas) first reported a position in Immunomedics Inc in Q1 2015 and held it in 4 quarters.
  • Highland Capital Management (Texas)'s Immunomedics Inc position peaked at $1.13M in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.